AGT and triple-A syndrome: It has been proposed that RXR activation may have a beneficial role in AAA by inhibiting the angiotensin type 1 receptor in vascular smooth muscle cells, a factor which is known to affect AAA development in angiotensin II–induced AAA models [56].